Novo’s Oral Semaglutide Delivers Similar Weight Loss To Wegovy In Phase III

A 50mg dose of oral semaglutide showed similar weight loss to the weekly injectable version that Novo already markets as Wegovy.

scale even
Oral semaglutide was on par with Wegovy in Phase III • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas